Children with resistant leukemia given CRISPR-edited T cells: Phase 1 study results reported
Understanding oral bacteria to help fight periodontal disease
27 October 2022After rehab for opioids, nearly half of Medicaid beneficiaries do not receive follow-up care
27 October 2022Children with resistant leukemia given CRISPR-edited T cells: Phase 1 study results reported
Researchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) have used CRISPR/Cas9 technology to engineer donor T cells to try to treat seriously ill children with resistant leukemia who had otherwise exhausted all available therapies.
